Tubocurarine Chloride

NDA 6095, held by Hospira. Tubocurarine Chloride.

As of Nov 13, 2026, NDA 6095 (Tubocurarine Chloride), held by Hospira, was first approved by FDA on Jan 30, 1947, with 33 approved supplements and 0 published complete response letters.

First approved: Jan 30, 1947
Review: Standard
Supplements approved: 33
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 34 submissions below

Date	Submission	Status	Documents
Jan 30, 1947	Original applicationNew formulation or manufacturer · Standard review	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Tubocurarine Chloride3MG/ML · injectable;injection	Tubocurarine Chloride	Discontinued

All 34 submissions, including labeling and manufacturing supplements


Feb 26, 1999	Supplement 38Labeling · Standard review	Approved	None posted
Feb 26, 1999	Supplement 34Labeling · Standard review	Approved	None posted
Jul 2, 1998	Supplement 37Manufacturing · Standard review	Approved	None posted
Oct 27, 1997	Supplement 36Manufacturing · Standard review	Approved	None posted
May 27, 1994	Supplement 35Manufacturing · Standard review	Approved	None posted
Nov 9, 1993	Supplement 31Manufacturing · Standard review	Approved	None posted
Mar 13, 1990	Supplement 32Manufacturing · Standard review	Approved	None posted
Feb 26, 1990	Supplement 33Manufacturing · Standard review	Approved	None posted
May 31, 1988	Supplement 29Manufacturing · Standard review	Approved	None posted
Feb 4, 1988	Supplement 30Labeling · Standard review	Approved	None posted
Jun 18, 1986	Supplement 26Labeling · Standard review	Approved	None posted
Jul 3, 1984	Supplement 28Manufacturing · Standard review	Approved	None posted
May 5, 1982	Supplement 27Labeling · Standard review	Approved	None posted
Jan 6, 1982	Supplement 25Labeling · Standard review	Approved	None posted
May 16, 1981	Supplement 23Manufacturing · Standard review	Approved	None posted
Apr 14, 1981	Supplement 24Manufacturing · Standard review	Approved	None posted
Mar 6, 1981	Supplement 22Manufacturing · Standard review	Approved	None posted
Oct 1, 1980	Supplement 18Manufacturing · Standard review	Approved	None posted
Oct 1, 1980	Supplement 17Labeling · Standard review	Approved	None posted
Jul 25, 1980	Supplement 20Manufacturing · Standard review	Approved	None posted
Jul 25, 1980	Supplement 19Manufacturing · Standard review	Approved	None posted
May 1, 1980	Supplement 15Labeling · Standard review	Approved	None posted
May 1, 1980	Supplement 14Manufacturing · Standard review	Approved	None posted
Apr 30, 1980	Supplement 16Labeling · Standard review	Approved	None posted
Jun 19, 1978	Supplement 13Labeling · Standard review	Approved	None posted
Oct 14, 1977	Supplement 12Manufacturing · Standard review	Approved	None posted
Sep 6, 1977	Supplement 9Manufacturing · Standard review	Approved	None posted
Sep 6, 1977	Supplement 8Labeling · Standard review	Approved	None posted
Sep 6, 1977	Supplement 7Manufacturing · Standard review	Approved	None posted
Jun 9, 1977	Supplement 11Manufacturing · Standard review	Approved	None posted
Jul 16, 1976	Supplement 6Manufacturing · Standard review	Approved	None posted
Apr 28, 1975	Supplement 5Labeling · Standard review	Approved	None posted
Oct 29, 1973	Supplement 1Labeling · Standard review	Approved	None posted
Jan 30, 1947	Original applicationNew formulation or manufacturer · Standard review	Approved	None posted

Identifiers

Application: NDA 6095
Drugs@FDA: Overview at FDA
Company: Hospira

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters